Stock Rich List
#572 on the rich list of 14,452 insiders

Martine A. Rothblatt

Chairperson & CEO at United Therapeutics; Director at BETA Technologies. Based in Silver Spring, Maryland.

$374M
in disclosed stock, −$12.2M (−3.16%) today
Market closed. Prices as of Nov 19, 4:04 PM ET
Rank
572nd of 14,452
Companies held
2
Largest holding
UTHR, 100.0% of total
Latest SEC filing
Nov 18, 2026

What the $374M is made of

Holdings counted

All filings on SEC.gov
CompanyHow heldSharesPriceValueShare of totalReported
United Therapeutics UTHR
Common Stock
Through Trust324,443$559.10$181M48.5%Form 4, Nov 18, 2026
United Therapeutics UTHR
Common Stock
Through Trust249,108$559.10$139M37.2%Form 4, Nov 18, 2026
United Therapeutics UTHR
Common Stock
Through Trust45,596$559.10$25.5M6.8%Form 4, Nov 18, 2026
United Therapeutics UTHR
Common Stock
Directly40,513$559.10$22.7M6.1%Form 4, Nov 18, 2026
United Therapeutics UTHR
Common Stock
Through Trust8,902$559.10$5.0M1.3%Form 4, Nov 18, 2026
BETA Technologies BETA
Class A common stock
Directly8,213$18.83$155K0.0%Form 4, Jun 11, 2026
United Therapeutics UTHR
Common Stock
Through Spouse166$559.10$93K0.0%Form 4, Nov 18, 2026

Share counts are the amounts Martine A. Rothblatt reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.

Open-market trades, last 12 months

DateTradeCompanySharesPriceValueFiling
Nov 18, 2026SoldUTHR120$570.82$68KView
Nov 18, 2026SoldUTHR80$571.63$46KView
Nov 18, 2026SoldUTHR140$573.40$80KView
Nov 18, 2026SoldUTHR259$574.36$149KView
Nov 18, 2026SoldUTHR201$575.26$116KView
Nov 18, 2026SoldUTHR440$576.65$254KView
Nov 18, 2026SoldUTHR909$577.59$525KView
Nov 18, 2026SoldUTHR838$578.59$485KView
Nov 18, 2026SoldUTHR628$579.55$364KView
Nov 18, 2026SoldUTHR420$580.76$244KView
Nov 18, 2026SoldUTHR696$581.79$405KView
Nov 18, 2026SoldUTHR439$582.80$256KView
Nov 18, 2026SoldUTHR123$583.74$72KView
Nov 18, 2026SoldUTHR77$584.95$45KView
Nov 18, 2026SoldUTHR40$586.74$23KView
Nov 17, 2026SoldUTHR373$576.16$215KView
Nov 17, 2026SoldUTHR1,017$577.14$587KView
Nov 17, 2026SoldUTHR1,763$578.17$1.0MView
Nov 17, 2026SoldUTHR1,127$579.11$653KView
Nov 17, 2026SoldUTHR955$580.13$554KView
Nov 17, 2026SoldUTHR1,112$581.18$646KView
Nov 17, 2026SoldUTHR449$582.57$262KView
Nov 17, 2026SoldUTHR2,004$583.22$1.2MView
Nov 17, 2026SoldUTHR381$584.22$223KView
Nov 17, 2026SoldUTHR79$585.27$46KView

Nearby on the list

Full list
Nearby ranks
RankNameStock holdingsToday
569Hamid R. Moghadam
Director, Prologis. San Francisco, CA
$376M−$5.7M (−1.49%)
570Alexis Borisy
Director, Revolution Medicines. Redwood City, CA
$375M−$1.0M (−0.27%)
571Roberta Bainum
10% owner, Choice Hotels International. Fulton, MD
$375M−$13.8M (−3.54%)
572Martine A. Rothblatt
Chairperson & CEO, United Therapeutics. Silver Spring, MD
$374M−$12.2M (−3.16%)
573Daniel J. Roberts
Co-Chief Executive Officer, IREN
$373M−$21.5M (−5.45%)
574William G. Roberts
Co-Chief Executive Officer, IREN
$373M−$21.5M (−5.45%)
575Kenneth Hao
Director, Broadcom. Palo Alto, CA
$371M−$7.9M (−2.09%)

Other United Therapeutics insiders

All UTHR insiders

Questions

How much stock does Martine A. Rothblatt own?

Martine A. Rothblatt holds $374,040,476 in listed stock based on SEC filings and current prices, mostly United Therapeutics (UTHR). That ranks 572nd on the Stock Rich List.

Is this Martine A. Rothblatt's net worth?

No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.

When did Martine A. Rothblatt last buy or sell stock?

The most recent open-market trade on file is a sale of 120 UTHR shares on Nov 18, 2026 at $570.82.